Exosomes Engineering and Their Roles as Therapy Delivery Tools, Therapeutic Targets, and Biomarkers. 2021

Nika Kučuk, and Mateja Primožič, and Željko Knez, and Maja Leitgeb
Faculty of Chemistry and Chemical Engineering, University of Maribor, Smetanova 17, 2000 Maribor, Slovenia.

Exosomes are becoming increasingly important therapeutic biomaterials for use in a variety of therapeutic applications due to their unique characteristics, especially due to the ineffectiveness and cytotoxicity of some existing therapies and synthetic therapeutic nanocarriers. They are highly promising as carriers of drugs, genes, and other therapeutic agents that can be incorporated into their interior or onto their surface through various modification techniques to improve their targeting abilities. In addition, they are biocompatible, safe, and stable. The review focuses on different types of exosomes and methods of their preparation, including the incorporation of different kinds of cargo, especially for drug delivery purposes. In particular, their importance and effectiveness as delivery vehicles of various therapeutic agents for a variety of therapeutic applications, including different diseases and disorders such as cancer treatment, cardiovascular and neurodegenerative diseases, are emphasized. Administration routes of exosomes into the body are also included. A novelty in the article is the emphasis on global companies that are already successfully developing and testing such therapeutic biomaterials, with a focus on the most influential ones. Moreover, a comparison of the advantages and disadvantages of the various methods of exosome production is summarized for the first time.

UI MeSH Term Description Entries
D005818 Genetic Engineering Directed modification of the gene complement of a living organism by such techniques as altering the DNA, substituting genetic material by means of a virus, transplanting whole nuclei, transplanting cell hybrids, etc. Genetic Intervention,Engineering, Genetic,Intervention, Genetic,Genetic Interventions,Interventions, Genetic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D016503 Drug Delivery Systems Systems for the delivery of drugs to target sites of pharmacological actions. Technologies employed include those concerning drug preparation, route of administration, site targeting, metabolism, and toxicity. Drug Targeting,Delivery System, Drug,Delivery Systems, Drug,Drug Delivery System,Drug Targetings,System, Drug Delivery,Systems, Drug Delivery,Targeting, Drug,Targetings, Drug
D055354 Exosomes A type of extracellular vesicle, containing RNA and proteins, that is secreted into the extracellular space by EXOCYTOSIS when MULTIVESICULAR BODIES fuse with the PLASMA MEMBRANE.
D020811 Biomedical Technology The application of technology to the solution of medical problems. Health Care Technology,Health Technology,Biomedical Technologies,Technology, Biomedical,Technology, Health,Technology, Health Care

Related Publications

Nika Kučuk, and Mateja Primožič, and Željko Knez, and Maja Leitgeb
June 2017, Pharmacology & therapeutics,
Nika Kučuk, and Mateja Primožič, and Željko Knez, and Maja Leitgeb
January 2021, Stem cells international,
Nika Kučuk, and Mateja Primožič, and Željko Knez, and Maja Leitgeb
June 2023, International journal of molecular sciences,
Nika Kučuk, and Mateja Primožič, and Željko Knez, and Maja Leitgeb
October 2022, Pharmaceutics,
Nika Kučuk, and Mateja Primožič, and Željko Knez, and Maja Leitgeb
June 2017, European review for medical and pharmacological sciences,
Nika Kučuk, and Mateja Primožič, and Željko Knez, and Maja Leitgeb
June 2022, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,
Nika Kučuk, and Mateja Primožič, and Željko Knez, and Maja Leitgeb
March 2024, Molecular therapy. Oncology,
Nika Kučuk, and Mateja Primožič, and Željko Knez, and Maja Leitgeb
March 2023, Biomolecules,
Nika Kučuk, and Mateja Primožič, and Željko Knez, and Maja Leitgeb
August 2021, Biomedicines,
Nika Kučuk, and Mateja Primožič, and Željko Knez, and Maja Leitgeb
March 2024, Biomolecules,
Copied contents to your clipboard!